ImagX Research Group

iMagX is a joint project between UCL (Université catholique de Louvain, Belgium) and IBA, world leader in proton therapy. Our interdisciplinary R&D team of 20 engineers, computer scientists, physicists and PhDs, works at the intersection of the scientific, clinical and industrial worlds, in order to create innovative imaging solutions to improve cancer treatment in proton therapy and radiotherapy.

The group works on the following projects In-vivo Image Guided Therapy and In-vivo Dose Guided Therapy.



  • Ion Beam Applications (IBA), Belgium.

ISPGroup Participants


MedicalmageProcessing ResearchCategoryAll

Last updated September 19, 2017, at 12:14 PM